calcium dobesilate has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Liu, C; Sun, D; Wang, N; Wang, Y; Zuo, B | 1 |
| Bu, X; Li, X; Su, J; Wang, F; Wei, D; Yan, F; Yuan, J; Zheng, W | 1 |
| Einarsdóttir, AB; Stefánsson, E | 1 |
| Gerss, J; Haritoglou, C; Kampik, A; Sauerland, C; Ulbig, MW | 1 |
| Caillon, P; Carneiro, AM; Cunha-Vaz, JG; Ribeiro, ML; Seres, AI; Stur, M; Zourdani, A | 1 |
2 trial(s) available for calcium dobesilate and Disease Exacerbation
| Article | Year |
|---|---|
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Topics: Adult; Aged; Analysis of Variance; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Hemostatics; Humans; Kaplan-Meier Estimate; Logistic Models; Macular Edema; Male; Middle Aged; Proportional Hazards Models; Risk Reduction Behavior; Severity of Illness Index; Time Factors | 2009 |
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Topics: Adult; Aged; Blood-Retinal Barrier; Calcium Dobesilate; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein; Fluorescein Angiography; Fluorophotometry; Hemostatics; Humans; Male; Middle Aged; Pilot Projects; Visual Acuity; Vitreous Body | 2006 |
3 other study(ies) available for calcium dobesilate and Disease Exacerbation
| Article | Year |
|---|---|
Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway.
Topics: Animals; Apoptosis; Calcium Dobesilate; Capillaries; Disease Models, Animal; Disease Progression; Fibrosis; Hemostatics; Human Umbilical Vein Endothelial Cells; Humans; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Sirtuin 1; Tumor Suppressor Protein p53 | 2020 |
Deletion of discoidin domain receptor 2 attenuates renal interstitial fibrosis in a murine unilateral ureteral obstruction model.
Topics: Administration, Oral; Animals; Calcium Dobesilate; Discoidin Domain Receptor 2; Disease Models, Animal; Disease Progression; Fibrosis; Humans; Kidney Tubules; Mice; Mice, Transgenic; Renal Insufficiency, Chronic; Sequence Deletion; Severity of Illness Index; Ureteral Obstruction | 2019 |
Prevention of diabetic retinopathy.
Topics: Calcium Dobesilate; Carbonic Anhydrase Inhibitors; Diabetic Retinopathy; Disease Progression; Fluorescein Angiography; Hemostatics; Humans; Macular Edema; Randomized Controlled Trials as Topic; Risk Reduction Behavior | 2009 |